A case study for a patient who required additional SGLT-2 inhibitors to help reduce progression of renal disease is presented, and Drs Robert Busch, Dhiren Patel, and Muthiah Vadugananthan share their final thoughts on renal protective agents.
Muthiah Vaduganathan, MD, MPH
Advertisement
Articles by Muthiah Vaduganathan, MD, MPH
Robert Busch, MD, and Muthiah Vadugananthan, MD, MPH, share their thoughts on the multifunctional responsibility of managing a patient’s renal disease.
Dr Robert Busch and Dr Muthiah Vadugananthan provide insights on educating their peers on the importance of decreasing renal progression.
An expert endocrinologist and cardiologist discuss the risks and complications of renal disease associated with diabetes and cardiovascular disease. Dr Robert Busch also provides an overview of some of the studies done in renal impairment.
Dhiren Patel, PharmD, CECES, BC-ADM, Robert Busch, MD, and Muthiah Vadugananthan, MD, MPH, provide an overview of the prevalence of renal impairment in patients with diabetes.
Advertisement
Latest Updated Articles
Advertisement
Advertisement
Trending on Medical Economics
1
Two cyber alerts in one week: What physicians need to do about PHP2Shell and the Quest Diagnostics breach
2
10 numbers show resident pay still falls short
3
Your AI scribe is saving you time. Is it also building the case against you?
4
Chiropractor accused of posing as doctor in $2 billion L.A. fraud bust; Amazon, Google and Meta push prior auth fixes; CMS can now exclude physicians on its own — Morning Medical Update Weekly Recap
5